P. Alijanipour Et Al. , "Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial," JOURNAL OF ARTHROPLASTY , vol.32, no.2, pp.628-634, 2017
Alijanipour, P. Et Al. 2017. Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial. JOURNAL OF ARTHROPLASTY , vol.32, no.2 , 628-634.
Alijanipour, P., Tan, T. L., Matthews, C. N., Viola, J. R., Purtill, J. J., Rothman, R. H., ... Parvizi, J.(2017). Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial. JOURNAL OF ARTHROPLASTY , vol.32, no.2, 628-634.
Alijanipour, Pouya Et Al. "Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial," JOURNAL OF ARTHROPLASTY , vol.32, no.2, 628-634, 2017
Alijanipour, Pouya Et Al. "Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial." JOURNAL OF ARTHROPLASTY , vol.32, no.2, pp.628-634, 2017
Alijanipour, P. Et Al. (2017) . "Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial." JOURNAL OF ARTHROPLASTY , vol.32, no.2, pp.628-634.
@article{article, author={Pouya Alijanipour Et Al. }, title={Periarticular Injection of Liposomal Bupivacaine Offers No Benefit Over Standard Bupivacaine in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial}, journal={JOURNAL OF ARTHROPLASTY}, year=2017, pages={628-634} }